Causal effects of lipid-lowering therapies on aging-related outcomes and risk of cancers: a drug-target Mendelian randomization study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Causal effects of lipid-lowering therapies on aging-related outcomes and risk of cancers: a drug-target Mendelian randomization study

Published:2023-12-19 Issue:24 Volume:15 Page:15228-15242
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Chen Han¹,Tang Xinyu²,Su Wei¹,Li Shuo¹,Yang Ruoyun¹,Cheng Hong³,Zhang Guoxin¹,Zhou Xiaoying¹

Affiliation:

1. Department of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China

2. Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China

3. Department of Neurology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China

Publisher

Impact Journals, LLC

Subject

Cell Biology,Aging

Reference34 articles.

1. Structural mechanism for statin inhibition of HMG-CoA reductase.;Deisenhofer;Science,2001

2. Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials.;Cholesterol Treatment Trialists’ Collaboration;Lancet,2019

3. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials.;Pedersen;Lancet,2015

4. Triglycerides and Residual Atherosclerotic Risk.;Fuster;J Am Coll Cardiol,2021

5. Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial.;Glynn;Lancet,2012

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic potential of single-nucleotide polymorphism-mediated IL6R inhibitors in ankylosing spondylitis treatment;Frontiers in Medicine;2024-05-21

2. The Causal Relationship between PCSK9 Inhibitors and Malignant Tumors: A Mendelian Randomization Study Based on Drug Targeting;Genes;2024-01-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3